Patients with type 2 diabetes should not skip breakfast
30-7-2015 • Jakubowicz et al., Diabetes Care 2015
Eating breakfast is important for patients with type 2 diabetes, because it improves glucose homeostasis throughout the day, and postprandial hyperglycaemia can be prevented.
Most, but not all women have better prognosis than men after acute myocardial infarction
29-7-2015 • Redfors et al., J Am Heart Assoc. 2015
While women have better adjusted prognosis than men after AMI, this benefit was not seen in younger women and women with STEMI and women are less likely to be prescribed evidence-based treatment.
Stroke detection and prevention in atrial fibrillation
23-7-2015 • Prof. Richard Hobbs - Br. J. Gen. Prac. 2015
Professor Richard Hobbs, Chairman of EPCCS Scientific Organising Committee, wrote an editorial in the July issue of Br J Gen Prac, in which three articles on stroke and its better prevention are published.
Shift work that interferes with preferred sleep timing may increase risk of type 2 diabetes
29-6-2015 • Vetter C et al., Diabetes Care 2015
Type of shift work affects the risk of type 2 diabetes, depending on whether someone is an early vs. late chronotype. When the preferred sleep timing is disrupted, risk of T2DM may increase.
Fewer heart failure hospitalisations with statins as primary or secondary prevention
24-6-2015 • Preiss D et al., Eur Heart J 2015
In primary and secondary prevention trials, statins lowered risk of the composite of non-fatal hospitalisation and HF death by ~10%, mostly driven by a fewer non-fatal hospitalisations.
News • 16-6-2015
Seeing your own calcified coronary arteries as a motivation to improve lifestyle
Patients with newly diagnosed coronary artery disease who looked at images of their own calcified coronary arteries were more likely to stop smoking, lose weight and take statins.
News • 30-7-2015
EPCCS consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
General practitioners representing various European countries discussed recent developments in the SPAF field, and specific implications for primary care in an expert meeting. This meeting resulted in a practical guidance for European GPs.
News • 27-7-2015
Another PCSK9-inbitor on its way to European approval for hypercholesterolaemia
The FDA has approved alirocumab injections, and the European EMA has recommended approval of this PCKS9-inhibitor as an adjunct to diet and other lipid-lowering drugs.
News • 22-7-2015
First PCSK9-inhibitor now approved by EMA for treatment of hypercholesterolaemia
Evolocumab is the first PCSK9 inhibitor to be approved worldwide, which means a milestone for patients
with uncontrolled cholesterol who require additional intensive LDL-C reduction.
News • 25-6-2015
Consensus paper on arrhythmia management from a patient preference perspective
European and international experts reviewed the evidence on patient values and preferences in the management of cardiac tachyarrhythmias and advise on best practice.
Physical activity can lower PCSK9 levels in 3 months time
24-6-2015 • Kamani et al., Eur J Clin Invest. 2015
Promoting to use the stairs instead of the elevator during 3 months lowered PCSK9 levels in a healthy population, implying that small lifestyle changes can improve PCSK9 levels.
News • 15-6-2015
Sleep quality affects risk of heart attack and stroke
According to results from the WHO MONICA study, poor sleep should be considered a risk factor for cardiovascular disease along with smoking, lack of exercise and poor diet.
EPCCS 8th Annual Scientific Meeting
September 17-18, 2015 , Prague, Czech Republic
20th WONCA Europe Conference
22 - 25 oktober 2015, Istanbul, Turkey
All upcoming meetings...
Meeting reports & resources
Report of 7th Annual EPCCS meeting held in Brussels.
Report of 6th Annual EPCCS meeting held in London
Report of 5th Annual EPCCS meeting held in Athens
Report of 4th Annual EPCCS meeting held in Berlin
All meeting reports...